| NCT Number | NCT07617285 |
| Lead Sponsor | Peking University People's Hospital
Collaborators: CARsgen Therapeutics Co., Ltd. |
| Conditions | AML, Refractory/Relapse Acute Myeloid Leukemia |
| Enrollment | 27 participants |
| Start Date | 2026-05-07 |
| Primary Completion | 2027-12-31 (estimated) |
| Study Completion | 2029-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-01 |